Could a Plant-Based powder cut the need for IV nutrition?

NCT ID NCT06904872

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 2 trial tests crofelemer, a plant-based oral powder, in 18 adults with short bowel syndrome and intestinal failure who rely on IV nutrition. Participants receive either a low dose, a higher dose, or a placebo for 24 weeks. The goal is to see if crofelemer safely reduces the amount of IV nutrition and stool volume needed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Crofelemer (oral powder)
What this could lead to
If it works, crofelemer could help reduce the amount of IV nutrition needed for people with short bowel syndrome, improving daily life.
What could go wrong
This is a small, early-phase trial with only 18 participants, so results may not apply to everyone. The drug may not work better than placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL GASTROINTESTINAL DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asklepios Klinik St. Georg

    RECRUITING

    Hamburg, 20099, Germany

  • Azienda Ospedaliera Universitaria Federico II

    RECRUITING

    Naples, 80131, Italy

  • Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi

    RECRUITING

    Bologna, 40138, Italy

  • Charité Universitätsmedizin

    RECRUITING

    Berlin, 10117, Germany

  • Ospedale Università di Padova

    RECRUITING

    Padova, 35128, Italy

  • Universitäatsklinik RWTH

    RECRUITING

    Aachen, 52074, Germany

  • Universitätsklinikum

    RECRUITING

    Essen, 45147, Germany

  • Universitätsmedizin

    RECRUITING

    Rostock, 18057, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.